1. All Products
  2. LAMIVUDINE (3TC), 50mg/5ml, oral sol., 240ml, bot.
Public Pricelist

LAMIVUDINE (3TC), 50mg/5ml, oral sol., 240ml, bot.

https://medicalguidelines.msf.org/en/node/428
https://unicat.msf.org/cat/product/12114
STD DORALAMI2S-

Valid Article

Former Code(s): DORAZYN1020
Article is intended to be used with children (<12 years) ONLY.
6.4.2.1 - Nucleoside/Nucleotide reverse transcriptase inhibitors
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AF05
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

LAMIVUDINE (3TC)

Therapeutic Action

Antiretroviral, nucleoside reverse transcriptase inhibitor (NRTI)

Indications

HIV infection, in combination with other antiretrovirals

The oral solutions are intended for PMTCT or treatment of neonates until they can switch to the preferred treatment option.

Instructions for use

When lamivudine is used in combination with other antiretrovirals, fixed-dose combinations (FDC) are available:

  • ABC 120 mg / 3TC 60 mg, disp. breakable tab.
  • ABC 600mg / 3TC 300mg, tab
  • AZT 300mg / 3TC 150mg, tab.
  • AZT 60mg / 3TC 30mg, disp. tab.
  • TDF 300mg / 3TC 300mg / DTG 50mg, tab.
  • TDF 300mg / 3TC 300mg, tab.

Storage

  • Below 25ºC
  • After opening, the oral solution keeps for 30 days maximum.